Carbon monoxide-releasing molecule-2 decreases fibrinolysis in human plasma

Blood Coagulation and Fibrinolysis

Volumn 20, Issue 6, 2009, Pages 448-455

  Nielsen, Vance G ^a,b,c   Kirklin, James K ^b   George, James F ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b University of Alabama at Birmingham   (United States)

^c HAHNEMANN UNIVERSITY HOSPITAL   (United States)

Author keywords

Carbon monoxide; Carbon monoxide releasing molecule; Coagulation; Fibrinolysis; Thrombelastography

Indexed keywords

ALPHA 2 ANTIPLASMIN; BLOOD CLOTTING FACTOR 13; PROTEIN CORM 2; THROMBIN; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR; UNCLASSIFIED DRUG;

ARTICLE; BLOOD CLOTTING; BLOOD SAMPLING; DISEASE COURSE; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; PRIORITY JOURNAL; THROMBOGENESIS;

ALPHA-2-ANTIPLASMIN; BLOOD COAGULATION; CARBON MONOXIDE; CARBOXYPEPTIDASE U; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; FACTOR XIII; FIBRINOGEN; FIBRINOLYSIS; HEMOSTATICS; HUMANS; ORGANOMETALLIC COMPOUNDS; PARTIAL THROMBOPLASTIN TIME; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTHROMBIN TIME; THROMBELASTOGRAPHY; THROMBOPLASTIN; TISSUE PLASMINOGEN ACTIVATOR;

EID: 69549108991     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32832f4335     Document Type: Article

References (15)

1. Wu L, Wang R. Carbon monoxide: endogenous production, physiological functions, and pharmacological applications. Pharmacol Rev 2005; 57:585-630. (Pubitemid 43036442)
2. True AL, Olive M, Boehm M, San H, Westrick RJ, Raghavachari N, et al. Heme oxygenase-1 deficiency accelerates formation of arterial thrombosis through oxidative damage to the endothelium, which is rescued by inhaled carbon monoxide. Circ Res 2007; 101:893-901.
3. Motterlini R, Clark JE, Foresti R, Sarathchandra P, Mann BE, Green CJ. Carbon monoxide-releasing molecules: characterization of biochemical and vascular activities. Circ Res 2002; 90:e17-e24.
4. Motterlini R. Carbon monoxide-releasing molecules (CO-RMs): vasodilatory, antiischaemic and anti-inflammatory activities. Biochem Soc Trans 2007; 35:1142-1146. (Pubitemid 350214248)
5. Motterlini R, Mann BE, Foresti R. Therapeutic applications of carbon monoxide-releasing molecules. Expert Opin Investig Drugs 2005; 14:1305-1318. (Pubitemid 41601449)
6. Megias J, Busserolles J, Alcaraz MJ. The carbon monoxide-releasing molecule CORM-2 inhibits the inflammatory response induced by cytokines in Caco-2 cells. Br J Pharm 2007; 150:977-986. (Pubitemid 46625094)
7. Brune B, Ullrich V. Inhibition of platelet aggregation by carbon monoxide is mediated by activation of guanylate cyclase. Mol Pharmacol 1987; 32:497-504. (Pubitemid 18006150)
8. Brune B, Schmidt KU, Ullrich V. Activation of soluble guanylate cyclase by carbon monoxide and inhibition by superoxide anion. Eur J Biochem 1990; 192:683-688. (Pubitemid 20316870)
9. Chlopicki S, Olszanecki R, Marcinkiewicz E, Lomnicka M, Motterlini R. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase. Cardiovasc Res 2006; 71:393-401. (Pubitemid 43949260)
10. Nielsen VG, Kirklin JK, George JF. Carbon monoxide releasing molecule-2 (CORM-2) increases the velocity of thrombus growth and strength in human plasma. Blood Coagul Fibrinolysis 2009; 20:377-380.
11. Dong D, Chen C, Huang W, Chen Y, Zhang X, Li Z, et al. Tricarbonyldichlororuthenium (II) dimer (CORM2) activates nonselective cation current in human endothelial cells independently of carbon monoxide releasing. Eur J Pharmacol 2008; 590:99-104.
12. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via Thrombelastography®: critical roles of fibrinogen and Factors II, VII, X and XII. Acta Anaesthesiol Scand 2005; 49:222-231.
13. Nielsen VG, Cohen BM, Cohen E. Elastic modulus-based thrombelastographic quantification of plasma clot fibrinolysis with progressive plasminogen activation. Blood Coagul Fibrinolysis 2006; 17:75-81. (Pubitemid 43170759)
14. Nielsen VG, Gurley WQ, Burch TM. Impact of factor XIII on coagulation kinetics and clot strength determined by thrombelastography. Anesth Analg 2004; 99:120-123.
15. Nielsen VG. Corn trypsin inhibitor decreases tissue-type plasminogen activator-mediated fibrinolysis of human plasma. Blood Coagul Fibrinolysis 2009; 20:191-196.